High-Dose and Adjuvanted Influenza Vaccines

Type: vaccine

Status: FDA Approved

Developer: Sanofi Pasteur, Seqirus

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026